Search

Yun Feng Xie

from Belvedere Tiburon, CA
Age ~60
Get Report
Also known as:
Yun F Xie, Yun Seng Xie, Michael Y Xie, Feng Xie Yun, Yunfeng F Xie, Yun Feng Xi, Yun Feng, Yungfeng Xie, Yu Feng, Xie Yun
Phone and address:
70 Marinero Cir, Tiburon, CA 94920
Related to:
Paul B O'Leary, 57Bin Guan YunMengyu Guan, 33Qing Yang XiaoDaniel Y Xie, 30Yunbin Guan, 59Yunbin Guan Bin, 59Yun YangXiaoqing Yang, 59Baoru Xue, 61Jennifer Yang
Connected to:
Aihua H Xie, 64Alice Xie, 31Angela Xie, 66Anita Xie, 38April M Xie, 66Betty L Xie, 60Bike Xie, 42Calvin Xie, 47Cathy Z Xie, 35Chengyu Xie, 45

Yun Xie Phones & Addresses

  • 70 Marinero Cir, Bel Tiburon, CA 94920
  • Belvedere Tiburon, CA
  • Wilmington, DE
  • 4526 Vereda Mar De Ponderosa, San Diego, CA 92130 (858) 922-7083
  • Carlsbad, CA
  • 11175 Kelowna Rd APT 5, San Diego, CA 92126

Professional Records

Medicine Doctors

Yun Xie Photo 1

Yun Xie

View page

Resumes

Resumes

Yun Xie Photo 2

Software Engineer At Sybase

View page
Location:
San Francisco Bay Area
Industry:
Computer Software

Publications

Us Patents

Inhibitors Of L2 Mediated Cell Adhesion

View page
US Patent:
6699888, Mar 2, 2004
Filed:
Jan 27, 2003
Appl. No.:
10/296907
Inventors:
Ila Sircar - San Diego CA
Yun Feng Xie - San Diego CA
Nicholas Smith - San Diego CA
Paul S. Furth - Bonita CA
Assignee:
Tanabe Seiyaku Co., Ltd. - Osaka
International Classification:
A61K 314439
US Classification:
514341, 5462741
Abstract:
The present invention relates to small molecules according to formula (I) that are potent inhibitors of mediated cell adhesion and which could be useful for the treatment of inflammatory diseases:.

Compounds And Compositions As Itpkb Inhibitors

View page
US Patent:
8178526, May 15, 2012
Filed:
Jun 12, 2008
Appl. No.:
12/664651
Inventors:
Badry Bursulaya - San Diego CA, US
Dai Cheng - San Diego CA, US
Jiqing Jiang - San Diego CA, US
Donald S. Karanewsky - Escondido CA, US
Yi Liu - San Diego CA, US
Shifeng Pan - San Diego CA, US
Yongqin Wan - Irvine CA, US
Xia Wang - San Diego CA, US
Yun Feng Xie - San Diego CA, US
Yang Yang - San Diego CA, US
Assignee:
IRM LLC - Hamilton
International Classification:
C07D 413/02
C07D 413/14
A61K 31/536
A61K 31/551
US Classification:
5142305, 51425213, 51425305, 51425306, 544 92, 544105, 544359, 544363
Abstract:
The invention provides a novel class of compounds of formula (I), pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or dysregulated B cell activities, particularly diseases or disorders that involve aberrant activation of inositol 1,4,5-trisphosphate 3-kinase B (ITPKb).

Compounds And Compositions As Hedgehog Pathway Inhibitors

View page
US Patent:
8507491, Aug 13, 2013
Filed:
Aug 24, 2009
Appl. No.:
13/060426
Inventors:
Dai Cheng - San Diego CA, US
Dong Han - San Diego CA, US
Guobao Zhang - San Diego CA, US
Yongqin Wan - Irvine CA, US
Yun Feng Xie - San Diego CA, US
Jiqing Jiang - San Diego CA, US
Wenqi Gao - San Diego CA, US
Shifeng Pan - San Diego CA, US
Assignee:
IRM LLC - Hamilton
International Classification:
A61K 31/501
A61K 31/4725
A61K 31/4439
A61K 31/497
A61K 31/472
A61K 31/4427
A61P 35/00
US Classification:
51425204, 514310, 51426322, 5142601, 514303, 51425505, 514309, 514308, 544238, 544264, 544255, 544331, 544408, 546143, 546118, 546141, 546140
Abstract:
The invention provides a method, compounds and compositions for modulating the activity of the hedgehog signaling pathway. In particular, the invention provides a method for inhibiting aberrant growth states resulting from phenotypes such as Ptc loss-of-function, hedgehog gain-of-function, smoothened gain-of-function or GIi gain-of-function, comprising contacting a cell with a sufficient amount of a compound of Formula (I).

Compounds And Compositions As Itpkb Inhibitors

View page
US Patent:
20090306039, Dec 10, 2009
Filed:
Jul 20, 2007
Appl. No.:
12/374481
Inventors:
Shifeng Pan - San Diego CA, US
Yi Liu - San Diego CA, US
Yun Feng Xie - San Diego CA, US
Dai Cheng - San Diego CA, US
yongqin Wan - Irvine CA, US
Dong Han - San Diego CA, US
Yang Yang - San Diego CA, US
Wenqi Gao - San Diego CA, US
Jiqing Jiang - San Diego CA, US
Badry Bursulaya - San Diego CA, US
Philip Chamberlain - San Diego CA, US
Donald Karanewsky - Escondido CA, US
Xia Wang - San Diego CA, US
International Classification:
A61K 31/496
C07D 403/06
C07D 401/14
C07D 403/14
C07D 413/14
A61K 31/506
A61K 31/551
A61K 31/5377
US Classification:
5142102, 544371, 544364, 544295, 540575, 544121, 51425405, 51425309, 51425219, 514218, 5142365
Abstract:
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated B cell activities, particularly diseases or disorders that involve aberrant activation of inositol 1,4,5-trisphosphate 3-kinase B (ITPKb).

Compounds And Compositions As Itpkb Inhibitors

View page
US Patent:
20110263610, Oct 27, 2011
Filed:
Mar 30, 2009
Appl. No.:
12/935273
Inventors:
Yongqin Wan - Irvine CA, US
Shifeng Pan - San Diego CA, US
Guobao Zhang - San Diego CA, US
Xia Wang - San Diego CA, US
Yun Feng Xie - San Diego CA, US
Jiqing Jiang - San Diego CA, US
Dean Phillips - San Marcos CA, US
Yang Yang - San Diego CA, US
Assignee:
IRM LLC - Hamilton
International Classification:
C07D 487/04
C07D 405/14
A61P 19/02
A61P 17/06
A61P 37/00
A61K 31/496
C07D 401/14
US Classification:
51425305, 51425304, 51425309, 544362, 544364, 544363
Abstract:
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated B cell activities, particularly diseases or disorders that involve aberrant activation of inositol 1,4,5-trisphosphate 3-kinase B (ITPKb).

Compounds And Compositions As Itpkb Inhibitors

View page
US Patent:
20120202782, Aug 9, 2012
Filed:
Apr 12, 2012
Appl. No.:
13/445644
Inventors:
Badry Bursulaya - San Diego CA, US
Dai Cheng - San Diego CA, US
Jiqing Jiang - San Diego CA, US
Donald S. Karanewsky - Escondido CA, US
Yi Liu - San Diego CA, US
Shifeng Pan - San Diego CA, US
Yongqin Wan - Irvine CA, US
Xia Wang - San Diego CA, US
Yun Feng Xie - San Diego CA, US
Yang Yang - San Diego CA, US
Assignee:
IRM LLC - Hamilton
International Classification:
A61K 31/536
A61K 31/551
A61K 31/496
A61K 31/4985
C07D 487/08
A61K 31/538
C07D 401/14
A61K 31/517
A61P 37/06
A61P 29/00
A61P 19/02
A61P 17/06
A61P 7/06
A61P 35/00
C07D 413/14
US Classification:
51421016, 540575, 514218, 544 92, 5142305, 544364, 5142531, 544 94, 544105, 544368, 51425402, 544363, 51425305, 544284, 51425217, 544 70
Abstract:
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or dysregulated B cell activities, particularly diseases or disorders that involve aberrant activation of inositol 1,4,5-trisphosphate 3-kinase B (ITPKb).

Hedgehog Pathway Modulators

View page
US Patent:
20130296333, Nov 7, 2013
Filed:
Jul 9, 2013
Appl. No.:
13/937477
Inventors:
Dai Cheng - San Diego CA, US
Dong Han - San Diego CA, US
Guobao Zhang - San Diego CA, US
Yongqin Wan - Irvine CA, US
Yun Feng Xie - San Diego CA, US
Jiqing Jiang - San Diego CA, US
Wenqi Gao - San Diego CA, US
Shifeng Pan - San Diego CA, US
International Classification:
C07D 401/12
C07D 473/00
C07D 401/14
C07D 405/14
C07D 409/14
C07D 471/04
US Classification:
51425204, 546141, 514309, 546143, 514310, 546140, 514308, 544279, 51426411, 544238, 546122, 514300, 544333, 514256, 544277, 51426322, 544405, 51425505
Abstract:
The invention provides a method, compounds and compositions for modulating the activity of the hedgehog signaling pathway. In particular, the invention provides a method for inhibiting aberrant growth states resulting from phenotypes such as Ptc loss-of-function, hedgehog gain-of-function, smoothened gain-of-function or Gli gain-of-function, comprising contacting a cell with a sufficient amount of a compound of Formula (I).

Crf Receptor Antagonists And Methods Relating Thereto

View page
US Patent:
57959056, Aug 18, 1998
Filed:
Jun 6, 1995
Appl. No.:
8/468799
Inventors:
James R. McCarthy - Solana Beach CA
Yun Feng Xie - Carlsbad CA
Jeffrey P. Whitten - San Diego CA
Thomas R. Webb - Olivenhain CA
Chen Chen - San Diego CA
John Y. Ramphal - Lafayette CO
Assignee:
Neurocrine Biosciences, Inc. - San Diego CA
International Classification:
A61K 3141
C07D24914
US Classification:
514383
Abstract:
CRF receptor antagonists are disclosed. Such receptor antagonists are thiadiazole-, pyrimidine-, triazine-, and triazole-containing compounds substituted with both a C3-C14 monocyclic or fused, homoaryl or heteroaryl group and a substituted amine group. The CFR receptor antagonists have utility in the treatment of a variety of disorders, including disorders associated with the hypersecretion of CRF.
Control profile
Yun Feng Xie from Belvedere Tiburon, CA, age ~60 Get Report